Skip to content

Patients › Elbow

鹰嘴滑囊炎

Olecranon bursitis — causes, symptoms, and when to seek urgent medical attention for infection.

Updated Aug 2026
一幅手绘插图,描绘了一个无脸的人将弯曲的肘部靠在桌子上,肘尖处有一个肿胀的软组织肿块。
鹰嘴滑囊炎:覆盖在肘部骨性突起的充满液体的缓冲垫(滑囊)肿胀,形成此处可见的典型“鹅蛋”样肿块。 Kieran Hirpara 4.0

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

您的感受

您可能会注意到肘尖处有一个明显的肿块。这种肿胀源于滑囊,这是一个充满液体的小囊,用于缓冲您的骨骼。在许多情况下,这种肿块不痛。然而,当您按压它或将肘部靠在硬表面上时,您可能会感到压痛。

如果肿胀是由感染引起的,您可能会感到更明显的疼痛。该区域可能会变红、触之发热并肿胀。您可能还会发烧。这些迹象表明您的身体正在对抗细菌。如果您长时间患有这种肿胀且没有好转,这可能是由于较少见的细菌类型所致。即使您的免疫系统健康,这种情况也可能发生。

您可能会发现日常任务变得困难。将手伸到背后扣内衣或把衬衫塞进裤子里可能会感到不适。完全弯曲手臂也可能感觉受限或疼痛。在肿胀一侧睡觉可能会压迫滑囊并扰乱您的休息。

在极少数情况下,您可能会在没有明显可见肿块的情况下经历疼痛。这可能是由于骨组织失去血液供应的状况所致。这种情况在成年人中并不常见,但会引起明显的不适。

如果您反复发作肿胀,重要的是要确定原因。有时,肘部的皮肤可能会破裂,形成看起来像感染的溃疡。这需要仔细评估以与标准滑囊炎区分开来。

我们理解应对肘部肿胀可能会令人沮丧。我们的方法侧重于了解您的具体症状,以指导正确的治疗。无论是简单的磨损还是持续性感染,我们都旨在缓解您的疼痛并恢复您的活动能力。

实际发生了什么

您的肘部有一个充满液体的小囊,称为鹰嘴滑囊。它位于您上臂骨(肱骨)远端鹰嘴突的正上方。您可以把它想象成一个微小的水气球或垫片。它的作用是在您弯曲手臂时,使皮肤能够在骨头上平滑滑动。

当这个囊受到刺激时,会积聚过多的液体。这会导致您看到和感觉到的肿胀。这并不是关节内部的关节炎,而是外部缓冲垫的问题。液体积聚会产生压力。这种压力会使该区域感觉紧绷、发热或触痛。

有时,细菌会进入这个空间。这会导致一种称为感染性滑囊炎的感染。身体会通过产生更多液体来对抗病菌。这会导致明显的红肿和发热。在其他情况下,则没有感染。这称为非感染性滑囊炎。它通常源于反复肘部支撑或直接撞击。

在一些慢性病例中,滑囊周围的组织会发生变化。您可能会在皮肤下摸到一条坚硬的索条。这是身体试图愈合该区域时形成的瘢痕组织。这些索条会使肿胀感觉更硬且灵活性降低。

如果肿胀不消退,可能会反复发作。液体会不断重新积聚。这就是为什么我们要探讨不同的管理方法。有些人通过休息和加压包扎获得缓解。其他人则需要更积极的治疗。

我们提供如引流液体或使用内镜清理受刺激组织等选项。内镜下清创术是一种简单、微创的手术。它有助于去除导致问题的炎症组织。对某些人来说,这种方法恢复迅速且疼痛轻微。

为您的具体情况选择正确的治疗方案非常重要。简单的感染通常仅通过抗生素即可治愈。您可能根本不需要手术。然而,如果滑囊反复积液,我们可能会建议完全切除它。这称为滑囊切除术。

了解实际发生的情况有助于您做出明智的选择。这不仅仅是移除液体。而是解决刺激的根源。这能确保您的肘部获得长期的舒适和功能。

我们能采取的措施

我们诊所采用的方法反映了 Mater Private Hospital Rockhampton 的上肢外科医生 Kieran Hirpara 医生对该疾病的管理方式。患者通过全科医生(GP)或物理治疗师的转诊来到我们诊所。我们首先进行全面评估,包括病史采集、体格检查,必要时进行影像学检查,以确诊。对于大多数病例,我们从非手术治疗开始。这包括改变日常活动以避免肘部受压、使用夹板支撑,以及参与物理治疗或手部治疗以恢复活动度。我们还考虑使用注射治疗来减轻炎症。我们通常仅在保守措施未能提供足够改善,或存在需要立即处理的急性结构性问题时才考虑手术。

如果肿胀是由感染(感染性滑囊炎)引起的,我们通常在不先引流液体的情况下进行经验性治疗。证据表明这种方法有效,且研究组中没有任何患者需要手术。如果肿胀未感染(无菌性滑囊炎),我们可能会使用注射治疗。最近的文献表明,对于非感染性病例的初始治疗,滑囊内注射和手术的不良事件发生率可能高于非侵入性管理。然而,对于对基本护理无反应的复发性病例,我们可能会提供多西环素硬化疗法或使用 50°C 至 52°C 之间的热量进行热消融。这些微创选项安全性高,且并发症少于开放手术。对于疼痛,我们可能会推荐抗炎药物。缓解持续时间因人而异,且取决于具体使用的治疗方法,因此我们会在咨询期间与您讨论预期的时间线。

当保守治疗达到极限或滑囊炎反复发作时,我们会考虑手术。我们可能会进行内镜下滑囊切除术,即通过小切口切除发炎的滑囊。该方法具有微创性、术后疼痛较少和恢复迅速的优点。在研究人群中,该手术未出现需要再次手术复发的病例或伤口愈合并发症。肱骨鹰嘴滑囊炎切除术后总体翻修率为 11.5%。在某些情况下,我们可能会用缝合线修复滑囊而不是将其切除,这可以提供功能和美容方面的好处。如果骨头上存在牵拉骨刺,或发现如分枝杆菌病等不寻常的感染,我们也会考虑手术。我们会与您回顾所有选项,以确保治疗方案符合您的需求和生活习惯。

预期情况

您的预后主要取决于您患有的滑囊炎类型。对于大多数非感染性滑囊炎病例,您的外科医生可能会首先推荐非侵入性管理。最近的证据表明,初始治疗时的注射或手术有时可能比保守治疗引起更多的不良反应。如果您的病情是单纯性且为感染性滑囊炎,不进行抽吸的经验性治疗通常有效。在这些情况下,没有患者需要进一步的手术。

如果您患有复发性或慢性滑囊炎,症状可能会持续或复发。如果保守治疗失败,您可能需要额外的手术。例如,在一组接受传统抽吸的患者中,11 人中有 8 人需要行滑囊切除术。滑囊切除术是切除发炎滑囊的手术。该手术后的复发率为 11.5%。这意味着大约每九名患者中就有一人可能需要再次手术。

恢复过程因治疗路径不同而感觉各异。内镜下滑囊切除术提供了一种简单且微创程度最低的手术方式。患者报告满意度高,且无复发或需要重返手术室处理的伤口愈合并发症。热消融是另一种针对复发病例的安全选择。它使用 50°C 至 52°C 之间的热量。这种方法比开放滑囊切除术并发症更少,且疗效相当。

某些因素会影响您的满意度。与没有鹰嘴索的患者相比,患有鹰嘴索(olecranon cords)的患者在手术切除后的满意度较低。鹰嘴索是瘢痕组织带。如果您有这种情况,您的外科医生会与您讨论这一风险。

在极少数情况下,滑囊炎可能由非典型分枝杆菌或原球藻(prototheca)等不寻常的感染引起。这些疾病通常病程迁延。如果您的肿胀未消退,您的外科医生会考虑这些病因。由于症状重叠,区分感染性和非感染性滑囊炎可能很困难。

总体而言,许多患者通过谨慎的管理都能获得良好的效果。您的外科医生会根据您的具体情况制定计划。请如实告知您的症状,以便我们为您选择最安全的治疗路径。

何时就诊

若肘部肿胀经休息后未见改善,请咨询全科医生。若出现发红、发热或发烧,请立即寻求紧急医疗护理,因为这些症状可能提示感染。区分感染性与非感染性肿胀有时较为困难。若疼痛持续数周,请要求专科医生评估。复发性肿胀需进行检查以排除罕见病因。切勿忽视突然加重、无力或关节交锁。这些症状可能提示更深层的问题,如骨质改变。早期评估有助于避免侵入性治疗带来的并发症。您的外科医生将首先引导您选择最安全、创伤最小的治疗方案。


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Nonsurgical management of olecranon bursitis is significantly more effective and safer than surgical management [1].
  • Empirical management of uncomplicated septic olecranon bursitis without aspiration is effective, with no patients requiring bursectomy [7].
  • Deferring aspiration in uncomplicated septic olecranon bursitis is a reasonable treatment option [12].
  • In a comparison of empirical management versus traditional aspiration for uncomplicated septic olecranon bursitis, 8 of 11 patients in the traditional aspiration group required bursectomy [7].
  • Nontuberculous mycobacterial olecranon bursitis should be considered in any patient with a swollen bursa and protracted course, regardless of immune status [5].
  • Intrabursal doxycycline sclerotherapy may be an effective alternative to surgical bursectomy for patients with recurrent olecranon bursitis refractory to conservative management [6].
  • Hydrothermal ablation at temperatures between 50°C and 52°C is a safe treatment option for recurrent or chronic olecranon bursitis with fewer complications than open bursectomy and comparable efficacy [14].
  • Endoscopic olecranon bursectomy for recalcitrant olecranon bursitis resulted in no recurrences or wound-healing complications necessitating return to the operating room [2].
  • The revision rate after bursectomy for olecranon bursitis is 11.5% [10].
  • Bursal suture repair is a viable alternative to bursectomy in selected patients with chronic traumatic olecranon bursitis, combining functional and cosmetic benefits [3].
  • Olecranon extrabursal endoscopic bursectomy provides a satisfactory view with less morbidity than the open method while avoiding a wound over the sensitive point of the olecranon [4].
  • Endoscopic debridement combined with compression suture for recalcitrant aseptic olecranon bursitis offers simple operation, minimal invasiveness, minimal postoperative pain, rapid recovery, a low recurrence rate, and satisfactory overall efficacy [17].
  • Patients with olecranon cords were less satisfied after surgical excision compared to those without cords [16].

Anatomy & Pathophysiology

  • Olecranon bursae can contain cords [16].
  • MR imaging is probably the method of choice for determining the development of olecranon bursae and their fluid content [19].
  • Distinguishing between septic and aseptic olecranon bursitis can be difficult because physical and laboratory data overlap [11].
  • Traumatic lesions of the olecranon bursa are common injuries associated with a high risk of complications [8].
  • Providers should maintain a high index of suspicion for full-thickness triceps tears in patients with specific risk factors and comprehensive musculoskeletal examination to ensure accurate diagnosis, as these tears can be misdiagnosed as olecranon bursitis [23].

Classification

  • Extrabursal endoscopic bursectomy provides a satisfactory view with less morbidity than the open method while avoiding a wound over the sensitive point of the olecranon [4].
  • Empirical management of uncomplicated septic olecranon bursitis without aspiration was effective, with no patients requiring bursectomy, whereas 8 of 11 patients in the traditional aspiration group required bursectomy [7].
  • Prospective studies are needed to guide optimal treatment for olecranon bursitis [9].
  • The revision rate after bursectomy for olecranon bursitis was 11.5% [10].
  • Distinguishing between septic and aseptic olecranon bursitis can be difficult because the physical and laboratory data overlap [11].
  • The first treatment line for olecranon bursitis is conservative, including ice, rest, anti-inflammatory and analgesic drugs and, occasionally, bursal fluid aspiration [15].
  • Pyoderma gangrenosum must be considered in the differential diagnosis whenever a patient presents with ulcerative cutaneous lesions that resemble an infectious process such as olecranon bursitis [18].

Investigations

  • Protothecal olecranon bursitis is a distinct entity that may require excision for cure [13].
  • MR imaging is probably the method of choice for determining both the development of the bursae and their fluid content [19].

Treatment

Non-Operative Management

  • Empirical management of uncomplicated septic olecranon bursitis without aspiration was found to be effective with no patients requiring bursectomy [7].

Operative Management

  • Endoscopic olecranon bursectomy provides a satisfactory view with less morbidity than the open method while avoiding a wound over the sensitive point of the olecranon [4].
  • Endoscopic debridement combined with compression suture for recalcitrant aseptic olecranon bursitis offers advantages including simple operation, minimal invasiveness, minimal postoperative pain, rapid recovery, a low recurrence rate, and satisfactory overall efficacy [17].
  • Excision has been curative for all lesions of the olecranon bursa in cases of protothecal infection [13].

Special Considerations

  • More prospective studies are needed to guide optimal treatment for olecranon bursitis [9].

Complications

  • Empirical management of uncomplicated septic olecranon bursitis was effective with no patients requiring bursectomy, whereas 8 of 11 patients in the traditional aspiration group required bursectomy [7].
  • Traumatic lesions of the olecranon bursa or prepatellar bursa are common injuries associated with a high risk of complications [8].
  • Excision has been curative for all lesions of the olecranon bursa, whereas multiple medications have been tried for cutaneous and systemic infections without clear-cut success [13].
  • Hydrothermal ablation at temperatures between 50C and 52C is a safe treatment option for recurrent or chronic olecranon bursitis with fewer complications than open bursectomy and a comparable efficacy [14].

Recovery

  • Empirical management of uncomplicated septic olecranon bursitis without aspiration is effective, with no patients in the empirical group requiring bursectomy [7].
  • Eight of 11 patients in the traditional aspiration group for uncomplicated septic olecranon bursitis required bursectomy [7].
  • Patients who underwent endoscopic olecranon bursectomy for recalcitrant olecranon bursitis experienced no recurrences or wound-healing complications necessitating return to the operating room [2].
  • Excision has been curative for all lesions of the olecranon bursa in cases of protothecal infection, whereas multiple medications have been tried for cutaneous and systemic infections without clear-cut success [13].

Key Evidence

  • [L4] Based primarily on level IV evidence, nonsurgical management of olecranon bursitis is significantly more effective and safer than surgical management. [1] (10.1007/s00402-014-2088-3)
  • [L4] In this population, patients who underwent endoscopic olecranon bursectomy experienced no recurrences or wound-healing complications necessitating return to the operating room. [2] (10.1016/j.asmr.2023.100832)
  • [L5] Bursal suture repair is a viable alternative to bursectomy in selected patients with chronic traumatic olecranon bursitis, combining functional and cosmetic benefits. [3] (10.1016/j.xrrt.2025.100597)
  • [L4] This approach provides a satisfactory view with less morbidity than the open method while avoiding a wound over the sensitive point of the olecranon. [4] (10.1097/bth.0b013e31829c0535)
  • [L4] Nontuberculous mycobacterial olecranon bursitis should be considered in any patient with a swollen bursa and protracted course, regardless of immune status. [5] (10.1016/j.jse.2008.07.009)
  • [L4] This may be an effective alternative to surgical bursectomy for patients with recurrent olecranon bursitis refractory to conservative management. [6] (10.1016/j.jhsg.2024.03.006)
  • [L4] Empirical management of uncomplicated septic olecranon bursitis was found to be effective with no patients requiring bursectomy, whereas 8 of 11 patients in the traditional aspiration group required bursectomy. [7] (10.1016/j.jhsa.2019.06.012)
  • [Paper] Traumatic lesions of the olecranon bursa or prepatellar bursa are common injuries associated with a high risk of complications. [8] (10.1007/s00402-017-2690-2)
  • [L5] More prospective studies are needed to guide optimal treatment. [9] (10.1016/j.jhsa.2021.02.006)
  • [L3] The revision rate after bursectomy for olecranon bursitis was 11.5%. [10] (10.1016/j.jse.2020.09.033)
  • [L5] Distinguishing between septic and aseptic olecranon bursitis can be difficult because the physical and laboratory data overlap. [11] (10.1016/j.jse.2015.08.032)
  • [L4] Deferring aspiration in uncomplicated septic olecranon bursitis is a reasonable treatment option. [12] (10.1016/j.jhsa.2018.06.059)
  • [Case_report] Excision has been curative for all lesions of the olecranon bursa, whereas multiple medications have been tried for cutaneous and systemic infections without clear-cut success. [13] (10.2106/00004623-198062050-00024)
  • [L4] Hydrothermal ablation at temperatures between 50C and 52C is a safe treatment option for recurrent or chronic olecranon bursitis with fewer complications than open bursectomy and a comparable efficacy. [14] (10.1016/j.jse.2024.03.021)
  • [L4] The first treatment line for olecranon bursitis is conservative, including ice, rest, anti-inflammatory and analgesic drugs and, occasionally, bursal fluid aspiration. [15] (10.1016/j.surge.2012.02.002)
  • [L4] Patients with olecranon cords were less satisfied after surgical excision compared to those without cords. [16] (10.1016/j.jse.2015.04.016)
  • [L4] Endoscopic debridement combined with compression suture for the treatment of aseptic olecranon bursitis has several advantages: simple operation, minimal invasiveness, minimal postoperative pain, rapid recovery, a low recurrence rate, and satisfactory overall efficacy. [17] (10.1186/s13018-024-05090-3)
  • [Case_report] PG must be considered in the differential diagnosis whenever a patient presents with ulcerative cutaneous lesions that resemble an infectious process such as olecranon bursitis. [18] (10.1016/j.jse.2014.06.032)
  • [L4] MR imaging is probably the method of choice for determining both the development of the bursae and their fluid content. [19] (10.1007/s002560050117)
  • [Case_report] Providers should maintain a high index of suspicion for triceps tears in patients with specific risk factors and comprehensive musculoskeletal examination to ensure accurate and timely diagnosis. [23] (10.1016/j.xrrt.2024.02.002)

References

[1] Treatment of olecranon bursitis: a systematic review. Archives of Orthopaedic and Trauma Surgery. 2014. DOI: 10.1007/s00402-014-2088-3

[2] No Wound Healing Complications or Recurrences Were Seen and a High Level of Satisfaction Was Reported in Patients Who Underwent Endoscopic Olecranon Bursectomy for Recalcitrant Olecranon Bursitis. Arthroscopy, Sports Medicine, and Rehabilitation. 2024. DOI: 10.1016/j.asmr.2023.100832

[3] Olecranon bursal repair for chronic traumatic bursitis: a surgical technique. JSES Reviews, Reports, and Techniques. 2026. DOI: 10.1016/j.xrrt.2025.100597

[4] Olecranon Extrabursal Endoscopic Bursectomy. Techniques in Hand & Upper Extremity Surgery. 2013. DOI: 10.1097/bth.0b013e31829c0535

[5] Nontuberculous mycobacterial olecranon bursitis: Case reports and literature review. Journal of Shoulder and Elbow Surgery. 2009. DOI: 10.1016/j.jse.2008.07.009

[6] Intrabursal Doxycycline Sclerotherapy for Recurrent Olecranon Bursitis of the Elbow: A Case Control Study. Journal of Hand Surgery Global Online. 2024. DOI: 10.1016/j.jhsg.2024.03.006

[7] Empirical Treatment of Uncomplicated Septic Olecranon Bursitis Without Aspiration. The Journal of Hand Surgery. 2020. DOI: 10.1016/j.jhsa.2019.06.012

[8] Treatment and outcome with traumatic lesions of the olecranon and prepatellar bursa: a literature review apropos a retrospective analysis including 552 cases. Archives of Orthopaedic and Trauma Surgery. 2017. DOI: 10.1007/s00402-017-2690-2

[9] Clinical Management of Olecranon Bursitis: A Review. The Journal of Hand Surgery. 2021. DOI: 10.1016/j.jhsa.2021.02.006

[10] Factors associated with revision surgery for olecranon bursitis after bursectomy. Journal of Shoulder and Elbow Surgery. 2021. DOI: 10.1016/j.jse.2020.09.033

[11] Olecranon bursitis. Journal of Shoulder and Elbow Surgery. 2016. DOI: 10.1016/j.jse.2015.08.032

[12] Empiric Treatment of Uncomplicated Septic Olecranon Bursitis Without Aspiration. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2018.06.059

[13] Protothecal olecranon bursitis. A case report and review of the literature.. The Journal of Bone & Joint Surgery. 1980. DOI: 10.2106/00004623-198062050-00024

[14] Hydrothermal ablation in recurrent or chronic olecranon bursitis: a prospective study. Journal of Shoulder and Elbow Surgery. 2024. DOI: 10.1016/j.jse.2024.03.021

[15] Diagnosis and management of olecranon bursitis. The Surgeon. 2012. DOI: 10.1016/j.surge.2012.02.002

[16] The existence of cords in olecranon bursae. Journal of Shoulder and Elbow Surgery. 2015. DOI: 10.1016/j.jse.2015.04.016

[17] Clinical efficacy of endoscopic debridement combined with compression suture in the treatment of recalcitrant aseptic olecranon bursitis. Journal of Orthopaedic Surgery and Research. 2024. DOI: 10.1186/s13018-024-05090-3

[18] Case report: misdiagnosed olecranon bursitis: pyoderma gangrenosum. Journal of Shoulder and Elbow Surgery. 2014. DOI: 10.1016/j.jse.2014.06.032

[19] The US,CT and MR findings of cubital bursitis: a report of five cases. Skeletal Radiology. 1996. DOI: 10.1007/s002560050117

[23] Full-thickness triceps tears misdiagnosed as olecranon bursitis: a case report. JSES Reviews, Reports, and Techniques. 2024. DOI: 10.1016/j.xrrt.2024.02.002

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.